河南科技大學(xué)第一附屬醫(yī)院申購petct匯報(bào)材料-全文預(yù)覽
【正文】 nfarct size 173 Included in 6mo followup With anterior STEMI without shock were randomized and enrolled at 30 sites in 9countries from June 2020 through February 2020 ?CRISP AMI Randomized Trial IABP應(yīng)用的偱證研究 By 6 months, 3 patients (%。367: 12881296 IABP應(yīng)用的偱證研究 At 30 days, mortality was similar among patients in the IABP group and those in the control group (% and %, respectively。91) 再梗死率、血運(yùn)重建及卒中：兩組均無明顯差異 (p≤0 謝謝大家！ 20201116 。 ? 嚴(yán)重急性心肌梗死 ： 并發(fā)心源性休克者應(yīng)盡快實(shí)施血運(yùn)重建治療是挽救患者的關(guān)鍵 ,而藥物治療后血液動(dòng)力學(xué)不能迅速穩(wěn)定者應(yīng)用 IABP支持 。 95% confidence interval [CI], to 。95%CI,%%) In the PCI alone group had died (logrank test P=.12） IABP應(yīng)用的偱證研究 ?CRISP AMI Randomized Trial 600 patients with AMI and cardiogenic shock enrolled 301 randomized to IABP 288 received IABP 13 did not receive IABP 299 randomized to control 269 received control therapy 30 crossover to IABP 287 primary PCI 3 primary CABG 11 no revascularization 288 primary PCI 3 primary CABG 8 no revascularization 300 with 30day followup 298 with 30day followup Allocation Revascularization Followup From June 16, 2020 to March 3, 2020, 790 patients with cardiogenic shock at 37 centers in Germany were screened IABP應(yīng)用的再評價(jià) :IABPSHOCK II TRIAL ?IABPSHOCK Ⅱ 試驗(yàn)： ? 首項(xiàng)有關(guān)在急性心肌梗死合并心源性休克患者中 IABP 應(yīng)用價(jià)值的開放、隨機(jī)、對照研究 ? 20 6 2020 、 3 ? 德國 37個(gè)臨床中心 ? 最
教學(xué)課件相關(guān)推薦
鄂ICP備17016276號(hào)-1